Whitney Ijem
Stock Analyst at Canaccord Genuity
(4.77)
# 575
Out of 4,356 analysts
374
Total ratings
48.5%
Success rate
21.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCGN Ocugen | Maintained: Buy | $12 → $11 | $1.38 | +697.10% | 5 | May 27, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $116 → $111 | $57.29 | +93.75% | 20 | May 22, 2026 | |
| PVLA Palvella Therapeutics | Maintained: Buy | $227 | $118.46 | +91.63% | 19 | May 21, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $75 | $32.93 | +127.76% | 5 | May 21, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $43 | $6.58 | +553.50% | 15 | May 19, 2026 | |
| TNYA Tenaya Therapeutics | Maintained: Buy | $5 | $0.869 | +475.37% | 24 | May 18, 2026 | |
| NGNE Neurogene | Maintained: Buy | $180 | $28.34 | +535.14% | 4 | May 12, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | $58 → $49 | $14.07 | +248.26% | 21 | May 12, 2026 | |
| GUTS Fractyl Health | Maintained: Buy | $8 | $0.8062 | +892.31% | 15 | May 12, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $79 | $23.94 | +229.99% | 22 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $7.92 | +165.15% | 28 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $12.99 | +184.83% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.07 | +225.73% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $143 | $88.32 | +61.91% | 28 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $5.87 | +189.61% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $441 → $436 | $447.54 | -2.58% | 37 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $429 | $301.98 | +42.06% | 34 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $5.77 | +298.61% | 15 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $114 | $309.03 | n/a | 5 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $17.87 | n/a | 2 | Sep 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $134.43 | n/a | 4 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $96.74 | n/a | 1 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.53 | n/a | 4 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $27 | $101.50 | n/a | 2 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 | $0.217695 | n/a | 5 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.46 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $56.18 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $31.17 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $16 | $9.10 | n/a | 5 | May 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.85 | n/a | 2 | Jan 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.77 | n/a | 1 | May 13, 2014 |
Ocugen
May 27, 2026
Maintained: Buy
Price Target: $12 → $11
Current: $1.38
Upside: +697.10%
BioMarin Pharmaceutical
May 22, 2026
Maintained: Buy
Price Target: $116 → $111
Current: $57.29
Upside: +93.75%
Palvella Therapeutics
May 21, 2026
Maintained: Buy
Price Target: $227
Current: $118.46
Upside: +91.63%
Beam Therapeutics
May 21, 2026
Maintained: Buy
Price Target: $75
Current: $32.93
Upside: +127.76%
Wave Life Sciences
May 19, 2026
Maintained: Buy
Price Target: $43
Current: $6.58
Upside: +553.50%
Tenaya Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $5
Current: $0.869
Upside: +475.37%
Neurogene
May 12, 2026
Maintained: Buy
Price Target: $180
Current: $28.34
Upside: +535.14%
Intellia Therapeutics
May 12, 2026
Reiterated: Buy
Price Target: $58 → $49
Current: $14.07
Upside: +248.26%
Fractyl Health
May 12, 2026
Maintained: Buy
Price Target: $8
Current: $0.8062
Upside: +892.31%
Ultragenyx Pharmaceutical
May 11, 2026
Maintained: Buy
Price Target: $79
Current: $23.94
Upside: +229.99%
May 8, 2026
Maintained: Buy
Price Target: $21
Current: $7.92
Upside: +165.15%
May 8, 2026
Maintained: Buy
Price Target: $37
Current: $12.99
Upside: +184.83%
May 7, 2026
Maintained: Buy
Price Target: $10
Current: $3.07
Upside: +225.73%
May 7, 2026
Maintained: Buy
Price Target: $140 → $143
Current: $88.32
Upside: +61.91%
May 6, 2026
Maintained: Buy
Price Target: $17
Current: $5.87
Upside: +189.61%
May 5, 2026
Maintained: Hold
Price Target: $441 → $436
Current: $447.54
Upside: -2.58%
May 4, 2026
Maintained: Buy
Price Target: $429
Current: $301.98
Upside: +42.06%
Apr 21, 2026
Maintained: Buy
Price Target: $23
Current: $5.77
Upside: +298.61%
Feb 28, 2022
Maintained: Buy
Price Target: $83 → $114
Current: $309.03
Upside: n/a
Sep 15, 2021
Upgraded: Buy
Price Target: n/a
Current: $17.87
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $134.43
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $96.74
Upside: n/a
Jun 25, 2020
Maintained: Hold
Price Target: n/a
Current: $28.53
Upside: n/a
Dec 16, 2019
Maintained: Buy
Price Target: $18 → $27
Current: $101.50
Upside: n/a
Nov 9, 2018
Downgraded: Hold
Price Target: $18
Current: $0.217695
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $3.46
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $56.18
Upside: n/a
Oct 9, 2018
Initiated Coverage: Buy
Price Target: $35
Current: $31.17
Upside: n/a
May 4, 2017
Reiterated: Buy
Price Target: $19 → $16
Current: $9.10
Upside: n/a
Jan 11, 2017
Maintained: Hold
Price Target: n/a
Current: $2.85
Upside: n/a
May 13, 2014
Maintained: Hold
Price Target: n/a
Current: $3.77
Upside: n/a